“Article: Highlights in urologic cancer” has been added to your cart. View cart

Article: P.05 The Combination of Decitabine and the Histone Deacetylase Inhibitor JNJ-26481585 Has Synergistic Anti-Myeloma Activity

€2.42

SKU: product-article-21172 Category: General

Description
Reviews (0)

Description

P.05 The Combination of Decitabine and the Histone Deacetylase Inhibitor JNJ-26481585 Has Synergistic Anti-Myeloma Activity

Reviews

There are no reviews yet.

Be the first to review “Article: P.05 The Combination of Decitabine and the Histone Deacetylase Inhibitor JNJ-26481585 Has Synergistic Anti-Myeloma Activity”

Top

Article: P.05 The Combination of Decitabine and the Histone Deacetylase Inhibitor JNJ-26481585 Has Synergistic Anti-Myeloma Activity

Description

Reviews

Related products

Article: Calendar of events

Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer

Article: Highlights in melanoma

Article: Highlights in gynaecological cancers